Generation Lab released SystemAge 2.1, a biological age test measuring 460+ biomarkers across 21 organ systems with sex-specific analysis and 99% validated accuracy. The platform tracks organ-level aging trajectories and quantifies treatment response to interventions including stem cells and plasma exchange, enabling practitioners to detect accelerated aging earlier and monitor intervention efficacy with precision.
Key Points
- Sex-specific biomarker analysis across 21 organ systems from single blood draw
- Measures Biological Noise via DNA methylation, claims superior accuracy vs. existing clocks
- Documents 5.5-year biological age reduction post-stem cell, 10.4-year immune reversal post-TPE
Longevity Analysis
Precision biological age measurement shifts from population-level estimates to individualized organ-system tracking, enabling detection of sex-dimorphic aging patterns and real-time quantification of intervention impact. The platform's capacity to measure mitochondrial function, reproductive hormonal status, and skin tissue aging across the full spectrum of organ systems addresses a critical gap: most longevity protocols operate without reliable feedback on whether specific interventions are actually modulating aging rate in the tissues that matter. Practitioners can now decode which treatments drive measurable reversal in their specific patient populations rather than relying on population averages.
Original published by LT Wire.